LEXIVA is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by State Of Florida Doh Central Pharmacy. The primary component is Fosamprenavir Calcium.
Product ID | 53808-1010_7c778d60-3b61-4b2b-9cf7-1a6b4ad3b7db |
NDC | 53808-1010 |
Product Type | Human Prescription Drug |
Proprietary Name | LEXIVA |
Generic Name | Fosamprenavir Calcium |
Dosage Form | Tablet, Film Coated |
Route of Administration | ORAL |
Marketing Start Date | 2014-11-01 |
Marketing Category | NDA / NDA |
Application Number | NDA021548 |
Labeler Name | State of Florida DOH Central Pharmacy |
Substance Name | FOSAMPRENAVIR CALCIUM |
Active Ingredient Strength | 700 mg/1 |
Pharm Classes | Protease Inhibitor [EPC],Cytochrome P450 3A4 Inhibitors [MoA],Cytochrome P450 3A4 Inducers [MoA],P-Glycoprotein Inducers [MoA],HIV Protease Inhibitors [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2019-12-31 |
Marketing Start Date | 2014-11-01 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA021548 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2014-11-01 |
Inactivation Date | 2020-01-31 |
Ingredient | Strength |
---|---|
FOSAMPRENAVIR CALCIUM | 700 mg/1 |
SPL SET ID: | b919bb7e-75f8-4df4-924c-54e829be0607 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
49702-207 | LEXIVA | fosamprenavir calcium |
49702-208 | LEXIVA | fosamprenavir calcium |
53808-0281 | LEXIVA | fosamprenavir calcium |
53808-1010 | LEXIVA | fosamprenavir calcium |
0378-3520 | Fosamprenavir Calcium | fosamprenavir calcium |
63304-583 | Fosamprenavir Calcium | Fosamprenavir Calcium |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
![]() LEXIVA 78312751 2928773 Live/Registered |
VIIV HEALTHCARE COMPANY 2003-10-13 |
![]() LEXIVA 78205433 2827902 Dead/Cancelled |
VIIV HEALTHCARE COMPANY 2003-01-21 |
![]() LEXIVA 75598528 not registered Dead/Abandoned |
SmithKline Beecham plc. 1998-12-03 |